免疫学
免疫系统
B细胞
细胞周期
分子医学
调节性B细胞
抗原呈递
抗原
自身免疫性疾病
生物
医学
疾病
细胞因子
免疫
癌症研究
B-1电池
CTLA-4号机组
抗原提呈细胞
自身免疫
体液免疫
免疫疗法
系统性红斑狼疮
临床试验
细胞疗法
T细胞
红斑狼疮
抗体
分泌物
获得性免疫系统
B细胞受体
细胞
作者
Zhiyuan Liu,Haoran Dai,Xiaoyu Cui,Yeping Liu,Zhaocheng Dong
标识
DOI:10.3892/ijmm.2025.5673
摘要
As a key component of the immune system, B cells primarily mediate humoral immunity via the synthesis and secretion of antibodies. In addition, B cells contribute to immune responses via antigen presentation and cytokine secretion. B cell‑targeted therapy has potential for the treatment of autoimmune diseases. However, current B cell‑targeted therapies have limited efficacy when used as monotherapies in clinical settings. In an aim to provide in‑depth understanding of this limitation, the present review discusses the developmental and differentiation pathways of B cells and the mechanisms by which various B cell subsets participate in immune responses, as well as randomized controlled trials on B cell‑targeted therapies conducted on lupus nephritis, an autoimmune disease with a notable inflammatory response. The clinical benefits of these therapies remain modest. This suggests that while B cells may serve a pathogenic role, existing therapies fail to address the fundamental mechanisms underlying disease progression. Targeting the interactions between B and T cells, particularly by inhibiting B cell‑mediated antigen presentation, may represent a promising novel direction for B cell‑targeted therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI